Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68 Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference-Reference-Cited by-同舟云学术

Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68 Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference

Published:2017-06 Issue:3 Volume:123 Page:472-477
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zamboglou Constantinos,Sachpazidis Ilias,Koubar Khodor,Drendel Vanessa,Wiehle Rolf,Kirste Simon,Mix Michael,Schiller Florian,Mavroidis Panayiotis,Meyer Philipp T.,Werner Martin,Grosu Anca L.,Baltas Dimos

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference52 articles.

1. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

2. Use of normal tissue complication probability models in the clinic;Marks;Int J Radiat Oncol Biol Phys,2010

3. IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and H-1-spectroscopic MRI;van Lin;Int J Radiat Oncol Biol Phys,2006

4. Intensity modulated radiation therapy dose painting for localized prostate cancer using C-11-choline positron emission tomography scans;Chang;Int J Radiat Oncol Biol Phys,2012

5. 11C-choline PET/pathology image coregistration in primary localized prostate cancer;Grosu;Eur J Nucl Med Mol Imaging,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on the Role of mpMRI and 68Ga-PSMA PET Imaging in Primary and Recurrent Prostate Cancer;Clinical Genitourinary Cancer;2024-06

2. Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study;Scientific Reports;2024-02-06

3. Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study;2023-09-26

4. Chancen der PSMA(prostataspezifisches Membranantigen)-Hybridbildgebung beim Prostatakarzinom;Die Urologie;2023-09-13

5. Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis;Cancers;2022-07-19